bf/NASDAQ:ICPT_icon.jpeg

COM:INTERCEPTPHARMA

Intercept Pharmaceuticals

  • Stock

USD

Last Close

18.96

07/11 21:00

Market Cap

794.69M

Beta: -

Volume Today

3.91M

Avg: -

Description

Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination with ursodeoxycholic acid in adults....Show More

competitor of